ArkBio Completes all Cohort Dosing in Australian Phase I Trial with Influenza AFC Drug AK0406 July 24, 2026 prnewswire.co.uk
Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth July 24, 2026 manilatimes.net
As AI backlash grows, Trump says firms should pay more for electricity July 24, 2026 straitstimes.com
scmp.com
